Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Nagi Bioscience
company
About
Nagi Bioscience aims to revolutionize the way toxic and/or beneficial effects of substances are tested.
- 1 - 10
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- Fr1.80M
- Industries
- Biotechnology
- Founded date
- Jan 1, 2019
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Nagi Bioscience aims to revolutionize the way toxic and/or beneficial effects of substances are tested today, by introducing the first “Organism-on-Chip” technology.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
Fr1.80M €2.50M
Nagi Bioscience has raised a total of
Fr1.80M €2.50M
in funding over 2 rounds. Their latest funding was raised on
Mar 21, 2022 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 21, 2022 | Grant | €2.50M | 1 |
European Innovation Council
|
— | Detail |
| Dec 20, 2019 | Seed | Fr1.80M | 2 |
Verve Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
3
Nagi Bioscience is funded by 3 investors.
European Innovation Council
and Verve Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
European Innovation Council
|
Yes | Grant |
|
Verve Ventures
|
Yes | Seed |
|
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
